Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
Clinical trial NCT00554983 · COMPLETED
Trial details
- NCT number
- NCT00554983
- Sponsor
- Allergopharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-06-01
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.